The goal of this research study is to compare the pregnancy rates for two different types of
progesterone supplementation after in-vitro fertilization (IVF).
The aim is to test the hypothesis that the pregnancy rates of women under age 40 undergoing
an in vitro fertilization and embryo transfer (IVF-ET) cycle are not different with respect
to the administration of progesterone (Crinone 8%, intravaginal gel versus intramuscular
- Women of reproductive age (21-39) with infertility who are appropriate candidates for
IVF/ET and have an FSH < 15 mIU/ml
- Women 21 to 39 years of age who have been assigned to stimulation of 2 to 8 amps of
Luteal Lupron/FSH or Luteal Lupron FSH/HMG.
- Women who have had more than 3 previous IVF/ET cycles